Search

Home > JACC's Audio Podcasts > Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction and Obesity: the SUMMIT Trial | JACC
Podcast: JACC's Audio Podcasts
Episode:

Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction and Obesity: the SUMMIT Trial | JACC
Category: Science & Medicine
Duration: 00:08:52
Publish Date: 2025-05-05 14:00:00
Description:

In this podcast, Dr. Valentin Fuster reviews findings from the SUMMIT trial, which examined how tirzepatide impacts patients with obesity-related heart failure with preserved ejection fraction (HFpEF) and chronic kidney disease (CKD). The study revealed that while tirzepatide improved cardiovascular outcomes and slightly boosted kidney function, the benefits in CKD patients may stem from mechanisms beyond glomerular filtration alone.
Total Play: 0

Users also like

100+ Episodes
Podcasts de .. 50+     7
400+ Episodes
CHEST Journa .. 10+     2
1 Episodes
JAMA Cardiol .. 10+     5

Some more Podcasts by American College of Cardiology

500+ Episodes
JACC: Clinic .. 10+     1
1K+ Episodes
JACC Podcast